Work

Third-Trimester HIV Viremia Treated With Long-Acting Cabotegravir and Rilpivirine: A Case Report

Year: 2025

Type: article

Abstract: We report the first case to quantitatively demonstrate a rapid and substantial viral load reduction using long-acting cabotegravir and rilpivirine in the third trimester of pregnancy. This case underscores the challenges some pregnant individuals face with daily oral antiretroviral therapy and the potential role of long-acting injectables in select scenarios.

Source: Open Forum Infectious Diseases

DOI: 10.1093/ofid/ofaf604

Authors: Noora Kazanji, Blake Max, Rodrigo M Burgos, Jennifer T Pham, Catherine E Ford

Institution: University of Illinois Chicago

Language: English

Topic: HIV/AIDS Research and Interventions

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $4,053